Companies / Kadence Bio
Kadence Bio
Company
Kadence Bio is a clinical-stage life sciences company developing novel therapeutics to address areas of significant unmet need in sexual and mental health.
Kadence Bio has 3 investors on file, among them Palo Santo, VOX Capital and XEIA Venture Partners. Its site was last checked 6 Nov 2026: site answers.
Investors
3 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Kadence Bio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Palo Santo adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/kadencebio.com/investors
# also
GET /v1/companies/kadencebio.com
GET /v1/companies/kadencebio.com/news